EyePoint, Inc. (EYPT) stock
EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$0.27−0.02 (-8.08%)
Close on Nov 18, 2026Market cap $23.45MP/E –Yield –
EyePoint revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
EyePoint's revenue for the twelve months ending Jun 30, 2026 was $2.79M, down 94.6% year over year. For fiscal 2025 it was $31.37M, down 27.5% from the year before. Over ten years it grew 24.6% a year on average. The highest annual figure on record is $46.02M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.37M | -27.5% |
| FY2024 | Dec 31, 2024 | $43.27M | -6.0% |
| FY2023 | Dec 31, 2023 | $46.02M | +11.1% |
| FY2022 | Dec 31, 2022 | $41.40M | +12.1% |
| FY2021 | Dec 31, 2021 | $36.94M | +7.3% |
| FY2020 | Dec 31, 2020 | $34.44M | +1063.0% |
| FY2018 | Jun 30, 2018 | $2.96M | -60.7% |
| FY2017 | Jun 30, 2017 | $7.54M | +365.4% |
| FY2016 | Jun 30, 2016 | $1.62M | -93.9% |
| FY2015 | Jun 30, 2015 | $26.57M | +664.9% |
| FY2014 | Jun 30, 2014 | $3.47M | +62.1% |
| FY2013 | Jun 30, 2013 | $2.14M | -39.2% |
| FY2012 | Jun 30, 2012 | $3.53M | -29.0% |
| FY2011 | Jun 30, 2011 | $4.97M | -78.5% |
| FY2010 | Jun 30, 2010 | $23.05M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $507.00K | -90.5% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $696.00K | -97.2% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $620.00K | -94.6% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $966.00K | -90.8% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $5.33M | -43.7% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $24.45M | +109.3% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $11.59M | -17.4% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $10.52M | -30.8% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $9.48M | +4.1% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $11.68M | +52.1% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $14.03M | +33.2% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $15.20M | +51.8% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $9.11M | -21.3% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $7.68M | -17.3% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $10.53M | -8.8% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $10.01M | +10.5% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $11.57M | +28.3% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $9.29M | +26.9% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $11.54M | +61.9% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $9.06M | -42.3% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $9.01M | +118.7% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $7.32M | -2.2% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $7.13M | +897.3% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $15.70M | +1591.3% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $4.12M | +341.8% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $7.49M | +1845.2% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $715.00K | +2.0% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $928.00K | +57.3% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $933.00K | -84.4% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $385.00K | +39.0% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $701.00K | +130.6% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $590.00K | +82.1% |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $5.97M | +1035.2% |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $277.00K | -40.6% |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $304.00K | -25.7% |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | $324.00K | -1.2% |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | $526.00K | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | $466.00K | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | $409.00K | – |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | $328.00K | – |
See a number that looks wrong?